Top Markets
#1 Akedo Akedo +69.97%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.06%
#4 Cross Cross +36.90%
#5 Velvet Velvet +31.95%
#6 Black Phoenix Black Phoenix +26.64%
#7 Cap Cap +22.61%
#8 OVERTAKE OVERTAKE +19.97%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.79%
#10 Ontology Gas Ontology Gas +11.65%
Coin of the day
Akedo Akedo
Настройки
Язык
Pусский
Валюта
USD
Тема
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

HEPA
Ранг среди акций #38693
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is... Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
Цена акции
$0.073
Рыночная капитализация
$849.99K
Изменение (1 день)
4.29%
Изменение (1 год)
21.67%
Страна
US
Торговля Hepion Pharmaceuticals, Inc. (HEPA)

Категория

Healthcare
Количество находящихся в обращении акций Hepion Pharmaceuticals, Inc. (HEPA)
Количество акций в обращении на August 2026: 0
Согласно последним финансовым отчетам и цене акций Hepion Pharmaceuticals, Inc., текущее количество акций в обращении составляет 0. На конец August 2026 у компании было 0 акций в обращении. Количество акций в обращении обычно зависит от сплитов и обратного выкупа акций.
История количества акций в обращении Hepion Pharmaceuticals, Inc. (HEPA) с 2026 по 2026
Акции в обращении на конец каждого года
Год Акции в обращении Изменить
Недостаточно данных для указанных дат.
Акции в обращении у аналогичных компаний или конкурентов
Компания Акции в обращении Разница Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE